{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-017490","form_type":"8-K","ticker":"ABBV","cik":"0001551152","company_name":"AbbVie Inc.","filed_at":"2025-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.971186+00:00","generated_at":"2026-05-26T03:33:40.545132+00:00","sec_items":["8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"AbbVie closes $4.0B senior notes offering across four maturities","bullets":["Closed $4.0B debt offering: $1.25B 4.650% notes due 2028, $1B 4.875% notes due 2030, $1B 5.200% notes due 2035, $750M 5.600% notes due 2055.","Notes are unsecured, unsubordinated obligations ranking equally with existing and future unsecured debt.","AbbVie may redeem notes at par after certain dates: 2028 notes after Feb 15, 2028; 2030 after Feb 15, 2030; 2035 after Dec 15, 2034; 2055 after Sep 15, 2054.","Proceeds not specified; offering registered under Form S-3ASR filed Feb 14, 2025, prospectus supplement dated Feb 18, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-017490","json":"https://secwatch.observer/filing/0001104659-25-017490.json","markdown":"https://secwatch.observer/filing/0001104659-25-017490.md","text":"https://secwatch.observer/filing/0001104659-25-017490.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1551152/000110465925017490/0001104659-25-017490-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1551152/000110465925017490/tm255723d7_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T03:33:40.545132+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}